The 11th annual PET meeting at the Royal Society of Medicine examined the role of PET/CT in oncology – covering issues such as the management of paediatric patients, applications within mesothelioma treatment, as well as the impact of new trials on lymphoma. LOUISE FRAMPTON reports.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
